Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Glaxosmithkline (GSK) Share News

LONDON BRIEFING: London to open green ahead of Fed rate decision

19th Mar 2025 08:00

(Alliance News) - London's FTSE 100 is set to open higher on Wednesday despite a Wall Street slump, as Germany sets out its multi-million defence boost plan and investors await a Federal Reserve rate decision. Read More

LONDON BRIEFING: Phoenix Group "ahead of plan"; AstraZeneca makes buy

17th Mar 2025 07:49

(Alliance News) - Stocks in London are called to open flat on Monday, as investors digest plans by Chinese officials to boost consumption there, before focus later this week turns to central bank decisions. Read More

LONDON MARKET CLOSE: Global stocks knocked as trade war fears bite

4th Mar 2025 16:57

(Alliance News) - Stocks fell sharply on Tuesday on concerns tit-for-tit moves on tariffs would spark a full-blown trade war. Read More

GSK says US FDA accepts two depemokimab indication submissions

3rd Mar 2025 09:56

(Alliance News) - GSK PLC on Monday said the US Food & Drug Administration has accepted for review the biologics license application for depemokimab in two indications - for asthma with type 2 inflammation and for chronic rhinosinusitis with nasal polyps. Read More

LONDON MARKET OPEN: Stocks rise, Hunting pleases with Rival sale

3rd Mar 2025 08:53

(Alliance News) - Stock prices in London opened higher on Monday, ahead of the UK manufacturing PMI and following like releases from other regions. Read More

LONDON MARKET OPEN: Stocks flat but EnergyPathways surges

24th Feb 2025 09:03

(Alliance News) - Stock prices in London opened mostly flat on Monday, while across the channel Germany's election results have sparked uncertainty but also hopes of economic stimulus. Read More

GSK completes GBP1 billion IDRx purchase; starts GBP2 billion buyback

24th Feb 2025 08:32

(Alliance News) - GSK PLC on Monday said it has completed the acquisition of Boston, Massachusetts-based precision therapeutics firm IDRx Inc, adding to its growing portfolio of treatments for gastrointestinal cancers. Read More

LONDON BRIEFING: FTSE 100 slightly down; Prosus to buy Just Eat

24th Feb 2025 07:54

(Alliance News) - UK stocks were called essentially flat on Monday, while over in the US confusion continues within federal workforces. Read More

IN BRIEF: GSK adds Oxford University medical science head to board

21st Feb 2025 09:00

GSK PLC - London-based pharmaceutical company - Hires Gavin Screaton as a non-executive director, joining the board on May 1. Screaton is head of the Medical Sciences Division at the University of Oxford. He is "an expert in the field of immunology and infectious diseases, two areas of science critical to GSK," it says. Screaton replaces Jesse Goodman, who will step down at GSK's annual general meeting in May, after nine years on the board. GSK hasn't yet announced a date for its 2025 AGM. In 2024, it was held on May 8. Read More

GSK celebrates Nucala review in China for form of pulmonary disease

20th Feb 2025 09:47

(Alliance News) - GSK PLC on Thursday said its monoclonal antibody Nucala, also known as mepolizumab, has been accepted for review in China. Read More

LONDON MARKET OPEN: FTSE 100 underperforms but Centrica jumps

20th Feb 2025 09:04

(Alliance News) - European stocks opened mixed on Thursday, with the FTSE 100 underperforming, as Russia-Ukraine uncertainty, tariff worries and the possibility of higher for longer interest rates cloud over stocks. Read More

GSK gets US FDA approval for 5-in-1 meningitidis vaccine Penmenvy

17th Feb 2025 08:49

(Alliance News) - GSK PLC on Saturday said the US Food & Drug Administration has approved its vaccine against five common disease-causing serogroups of Neisseria meningitidis. Read More

LONDON BRIEFING: Assura rejects approach; Mony announces buyback

17th Feb 2025 07:49

(Alliance News) - London's FTSE 100 is called to open flat, following Friday's decline, with geopolitics and US tariff threats in focus. Read More

PRESS: Ken Griffin's Citadel bets GBP300 million against GSK - FT

14th Feb 2025 21:30

(Alliance News) - Hedge fund Citadel has made a GBP305 million bet against pharmaceuticals firm GSK PLC, the biggest short position against the company in more than a decade, according to the Financial Times. Read More

Activist Elliott Management third-biggest investor in BP — reports

14th Feb 2025 10:31

(Alliance News) - The hedge fund targeting BP PLC has built a stake in the fossil fuel company worth nearly GBP3.8 billion, according to reports, making it the third-biggest investor in the company. Read More

UK dividends calendar - next 7 days

13th Feb 2025 14:02

Read More

LONDON MARKET MIDDAY: FTSE 100 makes minor gain before US data

12th Feb 2025 12:03

(Alliance News) - European equities edged slightly higher on Wednesday afternoon, but trade lacked impetus as investors await a US inflation report. Read More

LONDON BROKER RATINGS: Morgan Stanley likes Astra; HSBC cuts Spectris

12th Feb 2025 09:58

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday: Read More

LONDON BRIEFING: Barratt Redrow eyes profit at top end of market view

12th Feb 2025 07:49

(Alliance News) - London's FTSE 100 is called to open flat on Wednesday, failing to replicate some more confident trade seen in Asia, with a US inflation reading ahead. Read More

LONDON BROKER RATINGS: Deutsche ups CMC Markets; HSBC likes Wizz Air

7th Feb 2025 09:05

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and on Thursday: Read More

FTSE 100 Latest
Value8,774.65
Change-17.15